96 related articles for article (PubMed ID: 7719580)
1. The clinical use of antithrombin concentrate in septicaemia.
Harper PL
Br J Hosp Med; 1994 Dec 14-1995 Jan 17; 52(11):571-4. PubMed ID: 7719580
[TBL] [Abstract][Full Text] [Related]
2. Antithrombin replacement in patients with sepsis and septic shock.
Giudici D; Baudo F; Palareti G; Ravizza A; Ridolfi L; D' Angelo A
Haematologica; 1999 May; 84(5):452-60. PubMed ID: 10329925
[TBL] [Abstract][Full Text] [Related]
3. A systematic review of antithrombin concentrate use in patients with disseminated intravascular coagulation of severe sepsis.
Wiedermann CJ; Kaneider NC
Blood Coagul Fibrinolysis; 2006 Oct; 17(7):521-6. PubMed ID: 16988545
[TBL] [Abstract][Full Text] [Related]
4. [Antithrombin: prospects in clinical practice. Sespsi: anticoagulant or anti-inflammatory agents?].
Imberti D
Minerva Anestesiol; 2003 May; 69(5):371-5. PubMed ID: 12768169
[TBL] [Abstract][Full Text] [Related]
5. A case of anorexia nervosa with disseminated intravascular coagulation syndrome.
Haruta I; Asakawa A; Ogiso K; Amitani H; Amitani M; Tsai M; Hamada S; Inui A
Int J Eat Disord; 2012 Apr; 45(3):453-5. PubMed ID: 22407868
[TBL] [Abstract][Full Text] [Related]
6. Sepsis, coagulation, and antithrombin: old lessons and new insights.
Levi M; Schouten M; van der Poll T
Semin Thromb Hemost; 2008 Nov; 34(8):742-6. PubMed ID: 19214912
[TBL] [Abstract][Full Text] [Related]
7. [Antithrombin].
Iba T; Nakarai E
Rinsho Byori; 2011 Feb; Suppl 147():167-70. PubMed ID: 21761766
[No Abstract] [Full Text] [Related]
8. [[Antithrombin III concentrates in the treatmetn of sepsis and septic shock: indictions, limits and future prospects] ].
Baudo F; de Cataldo F
Minerva Anestesiol; 2000 Nov; 66(11 Suppl 1):3-23. PubMed ID: 11213542
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis and treatment of disseminated intravascular coagulation in the septic patient.
Levi M
J Crit Care; 2001 Dec; 16(4):167-77. PubMed ID: 11815902
[TBL] [Abstract][Full Text] [Related]
10. Antithrombin concentrate use in disseminated intravascular coagulation of sepsis: meta-analyses revisited.
Wiedermann CJ
J Thromb Haemost; 2018 Mar; 16(3):455-457. PubMed ID: 29316235
[TBL] [Abstract][Full Text] [Related]
11. Recombinant antitrypsin Pittsburgh undergoes proteolytic cleavage during E. coli sepsis and fails to prevent the associated coagulopathy in a primate model.
Harper PL; Taylor FB; DeLa Cadena RA; Courtney M; Colman RW; Carrell RW
Thromb Haemost; 1998 Nov; 80(5):816-21. PubMed ID: 9843177
[TBL] [Abstract][Full Text] [Related]
12. Antithrombin and hypercoagulability in sepsis: insights from thrombelastography?
Hoffmann JN; Schick K
Crit Care; 2007; 11(1):115. PubMed ID: 17331267
[TBL] [Abstract][Full Text] [Related]
13. Antithrombin: anti-inflammatory properties and clinical applications.
Levy JH; Sniecinski RM; Welsby IJ; Levi M
Thromb Haemost; 2016 Apr; 115(4):712-28. PubMed ID: 26676884
[TBL] [Abstract][Full Text] [Related]
14. Neonatal sepsis: a challenge in hemostaseology.
Kreuz W; Veldmann A; Fischer D; Schlösser R; Volk WR; Ettingshausen CE
Semin Thromb Hemost; 1999; 25(6):531-5. PubMed ID: 10632474
[TBL] [Abstract][Full Text] [Related]
15. Antithrombin substitution therapy.
Schinzel H; Weilemann LS
Blood Coagul Fibrinolysis; 1998 Nov; 9 Suppl 3():S17-21; discussion S21-2. PubMed ID: 10102495
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology and clinical applications of human recombinant antithrombin.
Pal N; Kertai MD; Lakshminarasimhachar A; Avidan MS
Expert Opin Biol Ther; 2010 Jul; 10(7):1155-68. PubMed ID: 20528611
[TBL] [Abstract][Full Text] [Related]
17. Clinical review: molecular mechanisms underlying the role of antithrombin in sepsis.
Wiedermann CJ
Crit Care; 2006 Feb; 10(1):209. PubMed ID: 16542481
[TBL] [Abstract][Full Text] [Related]
18. [What is safe in the drug therapy of infection?].
Spilker D; Seiter A
Beitr Infusionther Klin Ernahr; 1983; 10():196-203. PubMed ID: 6360142
[No Abstract] [Full Text] [Related]
19. [How to use AT concentrate or recombinant thrombomodulin for the patients with sepsis analyzed by laboratory markers].
Eguchi Y; Yoshida T; Okabe H
Rinsho Byori; 2011 Feb; Suppl 147():213-5. PubMed ID: 21761775
[No Abstract] [Full Text] [Related]
20. The effect of antithrombin on the systemic inflammatory response in disseminated intravascular coagulation.
Nielsen JD
Blood Coagul Fibrinolysis; 1998 Nov; 9 Suppl 3():S11-5. PubMed ID: 10102494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
